Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yunkai Qie

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|August 14, 2015
[The value of taking surgical margin specimens during transurethral resection of bladder tumor in the diagnosis and treatment of non-muscle invasive bladder cancer]Yunkai Qie, Hailong Hu, Dawei Tian
Oncotargets and Therapy|April 23, 2016
The value of extensive transurethral resection in the diagnosis and treatment of nonmuscle invasive bladder cancer with respect to recurrence at the first follow-up cystoscopyYunkai Qie, Hailong Hu, Dawei Tian, et al.
Nano Letters|November 25, 2024
Hepatic Stellate Cell Membrane-Camouflaged Nanoparticles for Targeted Delivery of an Antifibrotic Agent to Hepatic Stellate Cells with Enhanced Antifibrosis EfficacyZhaoxia Cheng, Fenfen Li, Yunkai Qie, et al.
Ecotoxicology and Environmental Safety|June 6, 2022
Low-dose hexavalent chromium(VI) exposure promotes prostate cancer cell proliferation by activating MAGEB2-AR signal pathwayYunkai Qie, Diansheng Zhou, Zhouliang Wu, et al.
Experimental Cell Research|March 12, 2020
TACC3 promotes prostate cancer cell proliferation and restrains primary cilium formationYunkai Qie, Lin Wang, E Du, et al.
BMC Urology|January 31, 2024
Is switching intravesical chemotherapeutic agents beneficial in short-term recurrent high-risk non-muscle-invasive bladder tumors? A 5-year retrospective studyShuaiqi Chen, Guangyu Sun, Xiaoxu Chen, et al.
Nano Letters|August 13, 2024
Targeted Inhibition of Lymphovascular Invasion Formation with CREKA Peptide-Modified Silicasomes to Boost Chemotherapy in Bladder CancerZhouliang Wu, Bozhao Li, Yunkai Qie, et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|November 7, 2024
[Analysis of Clinicopathological Characteristics and Factors Affecting the Prognosis of Patients With Resectable Sarcomatoid Carcinoma of the Bladder]Shiwang Huang, Kaipeng Jia, Chong Shen, et al.
Technology and Health Care : Official Journal of the European Society for Engineering and Medicine|July 20, 2024
The prognostic significance and immune characteristics of bone morphogenetic proteins (BMPs) family: A pan-cancer multi-omics analysisChangsheng Chen, Yu Zhang, Yuda Lin, et al.
Carcinogenesis|September 25, 2018
Kinase PIM1 promotes prostate cancer cell growth via c-Myc-RPS7-driven ribosomal stressChangwen Zhang, Yunkai Qie, Tong Yang, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|August 14, 2015
[The value of taking surgical margin specimens during transurethral resection of bladder tumor in the diagnosis and treatment of non-muscle invasive bladder cancer]Yunkai Qie, Hailong Hu, Dawei Tian
Oncotargets and Therapy|April 23, 2016
The value of extensive transurethral resection in the diagnosis and treatment of nonmuscle invasive bladder cancer with respect to recurrence at the first follow-up cystoscopyYunkai Qie, Hailong Hu, Dawei Tian, et al.
Nano Letters|November 25, 2024
Hepatic Stellate Cell Membrane-Camouflaged Nanoparticles for Targeted Delivery of an Antifibrotic Agent to Hepatic Stellate Cells with Enhanced Antifibrosis EfficacyZhaoxia Cheng, Fenfen Li, Yunkai Qie, et al.
Ecotoxicology and Environmental Safety|June 6, 2022
Low-dose hexavalent chromium(VI) exposure promotes prostate cancer cell proliferation by activating MAGEB2-AR signal pathwayYunkai Qie, Diansheng Zhou, Zhouliang Wu, et al.
Experimental Cell Research|March 12, 2020
TACC3 promotes prostate cancer cell proliferation and restrains primary cilium formationYunkai Qie, Lin Wang, E Du, et al.
BMC Urology|January 31, 2024
Is switching intravesical chemotherapeutic agents beneficial in short-term recurrent high-risk non-muscle-invasive bladder tumors? A 5-year retrospective studyShuaiqi Chen, Guangyu Sun, Xiaoxu Chen, et al.
Nano Letters|August 13, 2024
Targeted Inhibition of Lymphovascular Invasion Formation with CREKA Peptide-Modified Silicasomes to Boost Chemotherapy in Bladder CancerZhouliang Wu, Bozhao Li, Yunkai Qie, et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|November 7, 2024
[Analysis of Clinicopathological Characteristics and Factors Affecting the Prognosis of Patients With Resectable Sarcomatoid Carcinoma of the Bladder]Shiwang Huang, Kaipeng Jia, Chong Shen, et al.
Technology and Health Care : Official Journal of the European Society for Engineering and Medicine|July 20, 2024
The prognostic significance and immune characteristics of bone morphogenetic proteins (BMPs) family: A pan-cancer multi-omics analysisChangsheng Chen, Yu Zhang, Yuda Lin, et al.
Carcinogenesis|September 25, 2018
Kinase PIM1 promotes prostate cancer cell growth via c-Myc-RPS7-driven ribosomal stressChangwen Zhang, Yunkai Qie, Tong Yang, et al.
Pageof 3